The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria Authors: T. Zuberbier, A.H. Abdul Latiff, M. Abuzakouk, S. Aquilina, R. Asero, D. Baker, B. Ballmer-Weber, C. Bangert, M. Ben-Shoshan, J.A. Bernstein, C. Bindslev-Jensen, K. Brockow, Z. Brzoza, H.J. Chong Neto, M. Church, P.R. Criado, I.V. Danilycheva, C. Dressler, L.F. Ensina, L. Fonacier, M. Gaskins, K. Gáspár, A. Gelincik, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, M. Grosber, E. Hamelmann, J. Hébert, M. Hide, A. Kaplan, A. Kapp, A. Kessel, E. Kocatürk, K. Kulthanan, D. Larenas-Linnemann, A. Lauerma, T. Leslie, M. Magerl, M. Makris, R.Y. Meshkova, M. Metz, D. Micallef, C.G. Mortz, A. Nast, H. Oude-Elberink, R. Pawankar, P. Pigatto, H. Ratti Sisa, M.I. Rojo Gutiérrez, S.S. Saini, P. Schmid-Grendelmeier, B. Sekerel, F. Siebenhaar, H. Siiskonen, A. Soria, P. Staubach-Renz, L. Stingeni, G. Sussman, A. Szegedi, S.F. Thomsen, Z. Vadas, C. Vesterga...
Artículo recomendado:
ResponderEliminarCross-reactivity in b-Lactam Allergy
Robert J. Zagursky, PhD, and Michael E. Pichichero, MD Rochester, NY
b-Lactam drugs (penicillins, amoxicillin, and cephalosporins)
account for 42.6% of all severe drug-induced anaphylaxis. In this
review, we focus on clinically significant immunologic crossreactivity
in patients with confirmed penicillin allergy to
cephalosporins, and the structural involvement of the R1 and R2
chemical side chains of the cephalosporins causing IgE-mediated
cross-reactivity with penicillin and other cephalosporins. Skin
tests predict IgE-mediated reactions and showed cross-reactivity
between penicillins and early generation cephalosporins that
shared side chains, but confirmatory challenge data are lacking.
Later-generation cephalosporins, which have distinct side chains,
do not have any skin test cross-reactivity with penicillin/
amoxicillin. There is debate as to the involvement of R2 side
chains as the antigenic determinants that cause IgE-mediated
hypersensitivity with various cephalosporins. Avoidance of
cephalosporins, when they are the drug of choice in a penicillinallergic individual, results in significant morbidity that outweighs the low risk of anaphylaxis. We conclude that there is ample evidence to allow the safe use of cephalosporins in patients with isolated confirmed penicillin or amoxicillinallergy.
Texto completo:
http://dx.doi.org/10.1016/j.jaip.2017.08.027